While our estimates of the prevalence of ILD in the anti-MDA5 subpopulation may therefore be an underestimate, particularly if some children have mild ILD, which responds to standard therapies, it does accurately represent the proportion with ILD diagnosed during routine clinical practice. This evidence concerns the gene IFIH1 and interstitial lung disease.